Trastuzumab for the Treatment of HER2-Positive Metastatic Gastric Cancer
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Trastuzumab for the Treatment of HER2-Positive Metastatic Gastric Cancer
Authors
Keywords
Trastuzumab, Evidence Review Group, Single Technology Appraisal, ToGA Trial, Appraisal Consultation Document
Journal
PHARMACOECONOMICS
Volume 31, Issue 3, Pages 185-194
Publisher
Springer Nature
Online
2013-01-31
DOI
10.1007/s40273-013-0023-z
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Retigabine for the Adjunctive Treatment of Adults with Partial-Onset Seizures in Epilepsy with and without Secondary Generalization
- (2013) Dawn Craig et al. PHARMACOECONOMICS
- Bevacizumab for Metastatic Colorectal Cancer
- (2012) Sophie Whyte et al. PHARMACOECONOMICS
- Eltrombopag for the Treatment of Chronic Immune or Idiopathic Thrombocytopenic Purpura
- (2012) Dwayne Boyers et al. PHARMACOECONOMICS
- Golimumab for the Treatment of Psoriatic Arthritis
- (2012) Huiqin Yang et al. PHARMACOECONOMICS
- Pazopanib for the First-Line Treatment of Patients with Advanced and/or Metastatic Renal Cell Carcinoma
- (2012) Mary Kilonzo et al. PHARMACOECONOMICS
- Omalizumab for the Treatment of Severe Persistent Allergic Asthma in Children Aged 6–11 Years
- (2012) Jane Burch et al. PHARMACOECONOMICS
- Erlotinib Monotherapy for the Maintenance Treatment of Non-Small Cell Lung Cancer after Previous Platinum-Containing Chemotherapy
- (2011) Rumona Dickson et al. PHARMACOECONOMICS
- Denosumab for the Prevention of Osteoporotic Fractures in Post-Menopausal Women
- (2011) Graham Scotland et al. PHARMACOECONOMICS
- Dronedarone for the Treatment of Atrial Fibrillation
- (2011) Claire McKenna et al. PHARMACOECONOMICS
- Dabigatran Etexilate for the Prevention of Venous Thromboembolism in Patients Undergoing Elective Hip or Knee Surgery
- (2011) Michael Holmes et al. PHARMACOECONOMICS
- A randomised phase II study of combination chemotherapy with epirubicin, cisplatin and capecitabine (ECX) or cisplatin and capecitabine (CX) in advanced gastric cancer
- (2010) Jina Yun et al. EUROPEAN JOURNAL OF CANCER
- Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial
- (2010) Yung-Jue Bang et al. LANCET
- Cetuximab for Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck
- (2010) Adrian Bagust et al. PHARMACOECONOMICS
- Single Technology Appraisal at the UK National Institute for Health and Clinical Excellence
- (2010) Mark Sculpher PHARMACOECONOMICS
- Alitretinoin for Severe Chronic Hand Eczema
- (2010) Mark Rodgers et al. PHARMACOECONOMICS
- Febuxostat for the Management of Hyperuricaemia in Patients with Gout
- (2010) Matt Stevenson et al. PHARMACOECONOMICS
- Meta-analysis of the REAL-2 and ML17032 trials: evaluating capecitabine-based combination chemotherapy and infused 5-fluorouracil-based combination chemotherapy for the treatment of advanced oesophago-gastric cancer
- (2009) A. F. C. Okines et al. ANNALS OF ONCOLOGY
- Capecitabine/cisplatin versus 5-fluorouracil/cisplatin as first-line therapy in patients with advanced gastric cancer: a randomised phase III noninferiority trial
- (2009) Y.-K. Kang et al. ANNALS OF ONCOLOGY
- Capecitabine and Oxaliplatin for Advanced Esophagogastric Cancer
- (2008) David Cunningham et al. NEW ENGLAND JOURNAL OF MEDICINE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now